Use of macrolides and tetracyclines for chronic inflammatory diseases. - Wikidata - awgldk - TriplyDB

Use of macrolides and tetracyclines for chronic inflammatory diseases.

Use of macrolides and tetracyclines for chronic inflammatory diseases.

http://www.wikidata.org/entity/Q35962028

about

Progress in matrix metalloproteinase research.Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.What are the roles of metalloproteinases in cartilage and bone damage?Periodontitis and rheumatoid arthritis: a review.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Dry eye disease: an immune-mediated ocular surface disorder.Dry eye syndrome.Topical azithromycin as a novel treatment for ocular rosacea.Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety.Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial.Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

P2860

Q33608536-603AD9E0-9A6D-43E4-8091-1E96C7B159E2 Q35840805-9FA01FC0-116C-467D-80B4-A7B3E5CC63FB Q36009930-ADF5A060-2D87-44B1-9F47-5DC70919FAC5 Q36274684-66F76E88-9E11-4E90-8339-148E19142F65 Q36292638-C30DF45F-3412-454C-B4FC-004172E415C0 Q36309246-ED31AF30-A87A-4B8B-94CB-12B1AEF5C84C Q36644577-0539A2E5-0F8A-4D38-B3B1-E5E9067A5042 Q36916372-F931F582-004C-4E8B-A559-8DF8BD7F0A74 Q42578739-9174188A-F4FD-468B-B547-886C88A2251A Q44033671-9DD23008-BC67-47AE-AABF-632317FF380B Q46496257-F04923FA-63D7-41EA-8E82-90A2D32728D8 Q46742158-A2D61E9E-1858-4821-A4DF-66DB0A3A24C1 Q50916304-45A75FBE-3F08-479E-BD62-71BB23EFAA24

P2860

Use of macrolides and tetracyclines for chronic inflammatory diseases.

http://www.wikidata.org/entity/Q35962028

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@ast

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@en

type

label

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@ast

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@en

prefLabel

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@ast

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@en

P1433

Q35962028-63CFFD4F-8C6F-431A-AD8B-E6F0E07B09E2

P1476

Q35962028-CDA634E1-5A26-436C-830C-B513F63E2D50

P2093

Q35962028-5271C07D-E1F4-4D3A-9BF8-058D8EB99C10

Q35962028-5B26EE24-15A4-45FC-AAE8-37E1C5A68BF5

Q35962028-93FF7725-31CA-4EB4-B49F-39DACAE45664

Q35962028-A556DA10-7204-4C5A-8A5D-2DBD9D6F1EE0

Q35962028-F149C5F3-4104-4AA0-9CFB-9E0AA8CE6172

P2860

Q35962028-00F84B25-D096-49FE-8D7D-ECBC0439B502

Q35962028-02CEB2AF-1154-47D8-B5A1-23D294F59D55

Q35962028-02CF66C8-66BD-40F8-A81F-F06272E2E89A

Q35962028-03D06E0E-276C-45D1-8035-974BE6A15A29

Q35962028-073874F4-EAAA-4FF2-AFBE-6FAE82E1563B

Q35962028-0C6CECC7-EC98-4329-A3C4-39686F971827

Q35962028-154C78AE-9A39-4F6C-BC8B-9B22845DD9E9

Q35962028-1E01779D-218D-435A-9F9D-C7C4332D9CAD

Q35962028-28561185-F3F3-4A02-B20E-FE09B4B778B2

Q35962028-2997D047-7374-4E8F-9E7B-6EE08995F21C

P304

Q35962028-84AFFD7A-8C3A-4F73-A5B8-70C2ADDE3B01

P31

Q35962028-E4A3357A-5746-4535-9CE4-B7A29E123AA4

P356

Q35962028-2DB948CD-9B57-48F3-8816-1BD6BA328B22

P407

Q35962028-7039D31D-FC05-45A6-876E-6DDD31D80DA1

P433

Q35962028-47C81423-8811-4C53-9542-5AB99A9936A3

P478

Q35962028-DDBEEA97-6ED0-437F-ADD4-1080ACC1671C

P577

Q35962028-212048CF-6639-4F90-BBFD-BBB59426CB76

P698

Q35962028-DC92A9E8-89CA-44BD-8CDF-C9B1A308CD4E

P921

Q35962028-F691E5A3-7146-48C0-851B-0C156603FB8A

P356

P1433

Annals of Pharmacotherapy

P1476

Use of macrolides and tetracyclines for chronic inflammatory diseases.

@en

P2093

Martin E Evans

http://www.w3.org/2001/XMLSchema#string

Matthew T Lane

http://www.w3.org/2001/XMLSchema#string

Robert H Schosser

http://www.w3.org/2001/XMLSchema#string

Robert P Rapp

http://www.w3.org/2001/XMLSchema#string

Stacy A Voils

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes

Atherosclerosis — An Inflammatory Disease

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

Tularemia as a biological weapon: medical and public health management.

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Anti-inflammatory effects of macrolides in lung disease.

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

P304

86-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1E282

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15562139

http://www.w3.org/2001/XMLSchema#string

P921